PLA2G4B Antikörper (N-Term)

Produktnummer ABIN927538

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch PLA2G4B in WB. Er zeigt eine Reaktivität gegenüber Human, Maus, Ratte und Rind (Kuh).

Kurzübersicht für PLA2G4B Antikörper (N-Term) (ABIN927538)

Target: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Reaktivität: Human, Maus, Ratte, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G4B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-PLA2G4B Antikörper

Bindungsspezifität: N-Term

Kreuzreaktivität: Maus, Ratte (Rattus), Rind (Kuh)

Aufreinigung: Purified

Immunogen: PLA2 G2 antibody was raised in rabbit using the N terminal of PLA2 2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

PLA2G4B Blocking Peptide, (ABIN939674), is also available for use as a blocking control in assays to test for specificity of this PLA2G4B antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu PLA2G4B

Target: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Andere Bezeichnung: PLA2G4B

Hintergrund: This gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD). Synonyms: Polyclonal PLA2G4B antibody, Anti-PLA2G4B antibody, phospholipase A2, group IVB, cytosolic antibody, FLJ42498 antibody, HsT16992 antibody, cPLA2-beta antibody.

Pathways: ER-Nucleus Signaling, VEGF Signaling